Patel Anish
Insider CIK 1967163 · ELVN Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2026-02-12 | 2026-02-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-09 | 2026-01-13 | 48,057 | $27.98 | $1.34M | 215,254 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-09 | 2026-01-13 | 243 | $28.50 | $6.9K | 215,011 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-10 | 1,705 | $21.78 | $37.1K | 263,311 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-10 | 4,958 | $20.76 | $102.9K | 265,016 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-11-07 | 2025-11-12 | 613 | $17.94 | $11.0K | 269,974 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-11-07 | 2025-11-12 | 6,054 | $17.35 | $105.0K | 270,587 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-10-07 | 2025-10-09 | 6,667 | $20.10 | $134.0K | 276,641 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-08 | 2025-09-10 | 6,667 | $20.24 | $134.9K | 283,308 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-07 | 2025-08-11 | 6,262 | $18.20 | $114.0K | 290,380 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-07 | 2025-08-11 | 405 | $18.93 | $7.7K | 289,975 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-07 | 2025-07-09 | 6,362 | $19.75 | $125.6K | 296,947 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-07 | 2025-07-09 | 305 | $20.69 | $6.3K | 296,642 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-09 | 2025-06-11 | 6,607 | $20.33 | $134.3K | 303,369 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-09 | 2025-06-11 | 60 | $21.16 | $1.3K | 303,309 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-07 | 2025-05-09 | 6,173 | $18.30 | $113.0K | 310,470 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-07 | 2025-05-09 | 104 | $19.87 | $2.1K | 309,976 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-07 | 2025-05-09 | 390 | $19.40 | $7.6K | 310,080 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-09 | 2,763 | $18.29 | $50.5K | 316,791 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-09 | 148 | $19.27 | $2.9K | 316,643 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-07 | 2025-04-09 | 3,756 | $17.81 | $66.9K | 319,554 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-03-07 | 2025-03-11 | 6,667 | $21.44 | $142.9K | 323,310 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-02-07 | 2025-02-10 | 6,667 | $21.93 | $146.2K | 329,977 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 171,000 | — | $0 | 171,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-01-07 | 2025-01-10 | 10,700 | — | $0 | 67 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-01-07 | 2025-01-10 | 2,000 | — | $0 | 827 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-01-07 | 2025-01-10 | 9,000 | — | $0 | 44,342 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-01-07 | 2025-01-10 | 90 | $24.60 | $2.2K | 336,644 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-01-07 | 2025-01-10 | 6,577 | $24.17 | $159.0K | 336,734 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-01-07 | 2025-01-10 | 1,440 | $24.56 | $35.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-01-07 | 2025-01-10 | 20,260 | $24.15 | $489.3K | 1,440 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-01-07 | 2025-01-10 | 9,000 | $2.48 | $22.3K | 21,700 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-01-07 | 2025-01-10 | 2,000 | $2.48 | $5.0K | 12,700 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-01-07 | 2025-01-10 | 10,700 | $1.12 | $12.0K | 10,700 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 716 | $30.00 | $21.5K | 343,311 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-16 | 2024-07-16 | 1,547 | $25.01 | $38.7K | 344,027 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-15 | 2024-07-16 | 30,978 | $25.05 | $776.0K | 345,574 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-12 | 2024-07-16 | 17,475 | $25.07 | $438.1K | 376,552 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-06-06 | 2024-06-10 | 1,133 | — | $0 | 53,342 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-06-06 | 2024-06-10 | 1,133 | $20.06 | $22.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-06-06 | 2024-06-10 | 1,133 | $2.48 | $2.8K | 1,133 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-05-14 | 2024-05-16 | 1,107 | — | $0 | 54,475 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-05-14 | 2024-05-16 | 1,107 | $2.48 | $2.7K | 1,107 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-14 | 2024-05-16 | 1,107 | $25.00 | $27.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-05-09 | 2024-05-13 | 260 | — | $0 | 55,582 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-05-09 | 2024-05-13 | 260 | $2.48 | $645 | 260 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-09 | 2024-05-13 | 260 | $25.06 | $6.5K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-05-06 | 2024-05-08 | 4,875 | — | $0 | 55,842 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-06 | 2024-05-08 | 4,875 | $22.72 | $110.8K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-05-06 | 2024-05-08 | 4,875 | $2.48 | $12.1K | 4,875 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-11 | 2024-04-15 | 14,903 | — | $0 | 60,717 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-11 | 2024-04-15 | 14,903 | $2.48 | $37.0K | 17,500 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 17,500 | $25.03 | $438.0K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-08 | 2024-04-10 | 544 | $19.40 | $10.6K | 2,597 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-08 | 2024-04-10 | 4,331 | $18.50 | $80.1K | 3,141 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-03-06 | 2024-03-08 | 4,875 | $15.64 | $76.2K | 7,472 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 185,000 | — | $0 | 185,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-06 | 2024-02-08 | 4,875 | $15.11 | $73.7K | 12,347 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-22 | 2024-01-24 | 4,875 | $15.14 | $73.8K | 17,222 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-02 | 2024-01-02 | 11,000 | $15.00 | $165.0K | 22,097 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-29 | 2024-01-02 | 20 | $15.00 | $300 | 33,097 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-28 | 2024-01-02 | 2,520 | $15.08 | $38.0K | 33,117 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-26 | 2023-12-27 | 102 | $15.01 | $1.5K | 35,637 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-22 | 2023-12-27 | 983 | $15.03 | $14.8K | 35,739 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 206,000 | — | $0 | 206,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 10,767 | — | $0 | 10,767 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 2,827 | — | $0 | 2,827 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 75,620 | — | $0 | 75,620 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 394,027 | — | $0 | 394,027 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 36,722 | — | $0 | 36,722 | SEC↗ |